Editor in Chief
Prof. Krzysztof Jamroziak MD, PhD
Prof. Krzysztof Jamroziak MD, PhD is currently the Head of the Lymphoproliferative Diseases Ward in the Department of Haematology of Institute of Haematology and Transfusion Medicine in Warsaw, Poland. Between 2007 and 2013 he was an assistant professor at the Department of Haematology, Medical University of Lodz.
His major scientific interests include the design and conduct of investigator-initiated clinical trials in haematooncology, pharmacogenomics of anti-cancer agents, and genetic markers of susceptibility, sensitivity to treatment and prognosis of human haematologic malignancies, mainly plasma cell malignancies (especially multiple myeloma, AL amyloidosis and MGUS), and chronic lymphocytic leukaemia. He co-authored more than 100 scientific publications, published in prestigious foreign and domestic haematologic and oncologic journals. Prof. Jamroziak is also the vice-President of the Polish Myeloma Consortium (PMC), and an active member of the Polish Myeloma Group, and the Polish Adult Leukaemia Group (PALG). Within these organisations, he is involved mostly in the development of clinical trials initiated in Poland.
For the past several years, Prof. Jamroziak’s goal has been the improvement of the recognition and treatment of various types of amyloidosis in Poland. Prof. Jamroziak is the initiator of the the Polish Amyloidosis Network, an interdisciplinary organisation focused on the education of physicians and patients, and the promotion of scientific and clinical research on this rare group of diseases. Since 2017, he has also been the main organiser of the annual scientific conferences „Amyloidosis”, addressed to specialists in various fields dealing with the diagnosis and therapy of amyloidosis.
Bartosz Puła, MD, PhD
Bartosz Puła, MD, PhD graduated from the Faculty of Medicine at the Medical Academy in Wroclaw in 2011. After graduation, he started the specialisation training in pathomorphology at the Lower Silesian Oncology Center, at the same time conducting research at the Department of Histology at the Medical University of Wroclaw. He conducted many scientific projects on biology, diagnostics and treatment of cancers, especially breast, lung, and colon cancer. In 2014, he started the specialisation training in haematology at the Department of Haematology, at the Institute of Haematology and Transfusion Medicine in Warsaw. His current scientific interests focus on the pathogenesis, diagnostics, pharmacogenomics and individualised treatment of chronic lymphocytic leukaemia, multiple myeloma and amyloidosis. He is an author or a co-author of over 90 scientific articles, published in international and domestic haematologic and oncologic journals. His scientific achievements have been acknowledged by a START Scholarship of the Foundation for Polish Science, and the Scholarship for Outstanding Young Scientist by the Minister of Science and Higher Education. Dr. Puła is the president of the Young Haematologist Club of the Polish Society of Haematologists and Transfusionists, and an active member of the Polish Myeloma Group, and the Polish Adult Leukaemia Group. Within these organisations, he participates in the organisation of translation medicine research, and clinical trials. Since 2017, he is the assistant editor-in-chief of the „Hematologia” journal.
Sonia Dębek, MSc, BA
Sonia Dębek graduated from biotechnology at the Institute of Genetics and Biotechnology of the University of Warsaw, majoring in molecular biotechnology, as well as from English Studies at the Institute of English Studies, the University of Warsaw. She devoted her scientific work to RNA metabolism, especially to post-transcriptional stages. In addition to her work within the diploma theses, she gained experience in the laboratories of the Rockefeller University in New York, and the Institute of Molecular Biology in Mainz (Germany), as well as at the University of Antwerp (Belgium). After graduation, she worked in the Clinical Trials Department of the Institute of Haematology and Transfusion Medicine. Currently, she is a PhD candidate, and conducts her research on non-canonical functions of PIM kinases in Diffuse Large B-Cell Lymphoma, at the Institute of Haematology and Transfusion Medicine.